Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West Indies

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-47
SponsorCentre Hospitalier Universitaire de la Guadeloupe

About this trial

Genetics variants could be involved in atypical non-autoimmune diabetes revealed by ketoacidosis. The objective of this research will be to determine the relationships between the genetic variants already described in known monogenic diabetes or identified as involved in glucose metabolism and its regulation, in insulin signaling pathways or in insulin secretion itself in subjects of African and Indian ancestry with atypical forms of non autoimmune diabetes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

subjects of African and Indian ancestry with atypical forms of non autoimmune diabetes.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

118 Participants
are grouped into 1 trial group
Group A: case

Trial outcomes

Primary outcomes

1

known pathogenic mutations described in monogenic diabetes of the MODY type

pourcentage

Time frame
At inclusion

Secondary outcomes

1

new pathogenic mutations identified in genes involved in glucose metabolism and its regulation,

pourcentage

Time frame
At inclusion
2

genetic mutations.

présence/absence

Time frame
At inclusion
3

association between clinical and biological data and DNAI

odds ration

Time frame
At inclusion
4

comparing the genetic data found in African and Indian ancestry population

Results with a significant p-value (p \< 0.05)

Time frame
At inclusion

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: